JAM3 is highly enriched in leukemia-initiating cells and play an important role in the maintenance of leukemia-initiating cell stemness through LRP5/PDK1/AKT/GSK3β/β-catenin/CCND1 signaling pathways. The gene discussed is AKT1; the disease is leukemia.